Literature DB >> 3124877

Successful treatment of colon cancer in rats with recombinant interferon-gamma.

J N Ijzermans1, R L Marquet, E Bouwman, R W de Bruin, P H van der Meide, J Jeekel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3124877      PMCID： PMC2002389          DOI： 10.1038/bjc.1987.291

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  14 in total

1.  The purification and characterization of rat gamma interferon by use of two monoclonal antibodies.

Authors:  P H van der Meide; M Dubbeld; K Vijverberg; T Kos; H Schellekens
Journal:  J Gen Virol       Date:  1986-06       Impact factor: 3.891

2.  Immune (gamma) interferon produced by a human T-lymphoblast cell line.

Authors:  I Nathan; J E Groopman; S G Quan; N Bersch; D W Golde
Journal:  Nature       Date:  1981-08-27       Impact factor: 49.962

3.  The effect of Kupffer cell stimulation or depression on the development of liver metastases in the rat.

Authors:  H J Pearson; J Anderson; J Chamberlain; P R Bell
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.

Authors:  E S Kleinerman; L M Ceccorulli; E Bonvini; R Zicht; J I Gallin
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

5.  Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth.

Authors:  K Pfizenmaier; H Bartsch; P Scheurich; B Seliger; U Ucer; K Vehmeyer; G A Nagel
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

6.  Inhibitory effect of interferon on the growth of spontaneous mammary tumors in mice.

Authors:  E De Clercq; Z X Zhang; K Huygen; R Leyten
Journal:  J Natl Cancer Inst       Date:  1982-09       Impact factor: 13.506

7.  Direct cytolysis by partially-purified preparations of immune interferon.

Authors:  S Tyring; G R Klimpel; W R Fleischmann; S Baron
Journal:  Int J Cancer       Date:  1982-07-15       Impact factor: 7.396

8.  Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.

Authors:  G H Wong; I Clark-Lewis; L McKimm-Breschkin; A W Harris; J W Schrader
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

9.  Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon.

Authors:  D A Weigent; M P Langford; W R Fleischmann; G J Stanton
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307
View more
  1 in total

1.  The antitumour activity of the interferon inducer bropirimine is partially mediated by endogenous tumour necrosis factor alpha.

Authors:  M Scheringa; J N IJzermans; J Jeekel; R L Marquet
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.